Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Psychopharmacology

• Publication date

  2018-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00213-017-4823-2PMID 29305627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.

  2018cited by this paper
• A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey

  2017cited by this paper
• Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression

  2017cited by this paper
• The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.

  2016cited by this paper
• Network analysis of functional brain connectivity in borderline personality disorder using resting-state fMRI

  2016cited by this paper
• Brain network reorganization differs in response to stress in rats genetically predisposed to depression and stress-resilient rats

  2016influential reference
• Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains

  2016cited by this paper
• Divergent topological architecture of the default mode network as a pretreatment predictor of early antidepressant response in major depressive disorder

  2016cited by this paper
• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• Assessment of abnormal brain structures and networks in major depressive disorder using morphometric and connectome analyses.

  2016cited by this paper
• Species-conserved reconfigurations of brain network topology induced by ketamine

  2016cited by this paper
• Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression

  2016cited by this paper
• Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder

  2016cited by this paper
• Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.

  2016cited by this paper
• R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

  2015cited by this paper
• Pharmacological MRI (phMRI) of the Human Central Nervous System

  2015cited by this paper
• Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI

  2015influential reference
• Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat

  2014cited by this paper
• Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.

  2014cited by this paper
• Aberrant topology of striatum's connectivity is associated with the number of episodes in depression.

  2014cited by this paper
• Enhancing ketamine translational pharmacology via receptor occupancy normalization.

  2014cited by this paper
• Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

  2014cited by this paper
• Elucidating brain connectivity networks in major depressive disorder using classification-based scoring

  2014cited by this paper
• NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats

  2014cited by this paper
• Mechanisms of Reward Circuit Dysfunction in Psychiatric Illness

  2014cited by this paper
• GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine

  2014cited by this paper
• Affective state-dependent changes in the brain functional network in major depressive disorder.

  2014cited by this paper
• The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression

  2014cited by this paper
• Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampus.

  2013cited by this paper
• Neuroscientific Model of Motivational Process

  2013cited by this paper
• 1809 “ Domain Gauges ” : A Reference System for Multivariate Profiling of Brain fMRI Activation Patterns Induced by Psychoactive Drugs in Rats

  2013cited by this paper
• Delay-dependent impairment of spatial working memory with inhibition of NR2B-containing NMDA receptors in hippocampal CA1 region of rats

  2013cited by this paper
• Systems Genetics of the Lateral Septal Nucleus in Mouse: Heritability, Genetic Control, and Covariation with Behavioral and Morphological Traits

  2012cited by this paper
• Pharmacological modulation of functional connectivity: α2-adrenergic receptor agonist alters synchrony but not neural activation

  2012cited by this paper
• Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

  2012cited by this paper
• Machine learning classifier using abnormal brain network topological metrics in major depressive disorder

  2012cited by this paper
• Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.

  2012cited by this paper
• Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders

  2012cited by this paper
• Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy

  2012cited by this paper
• Discovering imaging endophenotypes for major depression

  2011cited by this paper
• Weight-conserving characterization of complex functional brain networks

  2011cited by this paper
• Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder.

  2011influential reference
• Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

  2010cited by this paper
• Comparison of alpha-chloralose, medetomidine and isoflurane anesthesia for functional connectivity mapping in the rat.

  2010cited by this paper
• The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.

  2010cited by this paper
• Complex network measures of brain connectivity: Uses and interpretations

  2010cited by this paper
• Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications.

  2009cited by this paper
• Hemispheric lateralization of the corticostriatal glutamatergic system in the rat

  2009cited by this paper
• Parcellation‐dependent small‐world brain functional networks: A resting‐state fMRI study

  2009cited by this paper
• Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potential

  2009cited by this paper
• Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

  2009cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Left-right asymmetry of the hippocampal synapses with differential subunit allocation of glutamate receptors

  2008cited by this paper
• Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.

  2008cited by this paper
• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  2008cited by this paper
• Neurobiological mechanisms of anhedonia

  2008cited by this paper
• The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys

  2007cited by this paper
• A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: Application to pharmacological MRI

  2006cited by this paper
• Brainstem correlates of defensive states in humans.

  2006cited by this paper
• Lack of ventral striatal response to positive stimuli in depressed versus normal subjects.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006influential reference
• Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

  2005cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2005cited by this paper
• Differential projections of the infralimbic and prelimbic cortex in the rat

  2004cited by this paper
• Asymmetrical Allocation of NMDA Receptor ε2 Subunits in Hippocampal Circuitry

  2003cited by this paper
• The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations.

  2003cited by this paper
• Asymmetrical allocation of NMDA receptor epsilon2 subunits in hippocampal circuitry.

  2003cited by this paper
• Congenital helpless rats as a genetic model for cortex metabolism in depression

  2000cited by this paper
• Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

  2000cited by this paper
• NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A.

  1999cited by this paper
• In Vitro Binding Properties in Rat Brain of [3H]Ro 25‐6981, a Potent and Selective Antagonist of NMDA Receptors Containing NR2B Subunits

  1998cited by this paper
• Dexmedetomidine Premedication Attenuates Ketamine‐induced Cardiostimulatory Effects and Postanesthetic Delirium

  1995cited by this paper
• Rearing rats with mice prevents induction of mouse killing by lesions of the septum but not lesions of the medial hypothalamus or medial accumbens.

  1984cited by this paper

• Structure-Activity Relationship of NMDA Receptor Ligands and Their Activities on the ERK Activation through Metabotropic Signaling Pathway

  2025cites this paper
• The neuroendocrine regulation of hepatic cytochrome P450 by N-methyl-D-aspartate receptors in the paraventricular and arcuate nuclei of the hypothalamus.

  2025cites this paper
• Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

  2025cites this paper
• Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice.

  2024cites this paper
• Perioperative intravenous infusion of dexmedetomidine for alleviating postpartum depression after cesarean section: A meta-analysis and systematic review.

  2024cites this paper
• Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation

  2023cites this paper
• Early life adversity impaired dorsal striatal synaptic transmission and behavioral adaptability to appropriate action selection in a sex-dependent manner

  2023cites this paper
• Autophagy promotes membrane trafficking of NR2B to alleviate depression by inhibiting AQP4 expression in mice.

  2022cites this paper
• The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain

  2022cites this paper
• Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome

  2021cites this paper
• The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver

  2021cites this paper
• Perisynaptic astrocytes as a potential target for novel antidepressant drugs.

  2021cites this paper
• Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study

  2021cites this paper
• Neural Engineering

  2020cites this paper
• Linear Dynamics and Control of Brain Networks

  2020cites this paper
• The influence of ketamine’s repeated treatment on brain topology does not suggest an antidepressant efficacy

  2020cites this paper
• The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence

  2020influential citation
• Sprouty1 regulates neuritogenesis and survival of cortical neurons

  2019cites this paper
• Effects of 5-Aza on p-Y1472 NR2B related to learning and memory in the mouse hippocampus.

  2019cites this paper
• Differences between ketamine’s short-term and long-term effects on brain circuitry in depression

  2019cites this paper
• NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats

  2019cites this paper
• Evaluation of the Wistar-Kyoto Rat Model of Depression and the Role of Synaptic Plasticity in Depression and Antidepressant Response.

  2019cites this paper
• Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review

  2019cites this paper
• Characterization of the Wistar-Kyoto rat model of depression in the context of hippocampal synaptic plasticity and ketamine’s antidepressant properties

  2019cites this paper
• Brain networks in pharmacological fMRI of NMDA antagonists

  2019cites this paper
• Linear Dynamics&Control of Brain Networks

  2019cites this paper
• An introduction to psychedelic neuroscience.

  2018cites this paper
• Ketamine: A Review for Clinicians.

  2018cites this paper
• World Journal of Hepatology

  year unknowncites this paper